Every round on record, with the sources behind each and the investors on them.
A commercial-stage radiopharmaceutical company advancing patient care by utilizing novel technologies to produce commercial-scale radioisotopes
northstarnm.comLinkedInBeloit, Wis.Founded 2006319 people
6 sources
Source 1 calls this a funding round and describes convertible preferred shares; the company release’s more specific description of a growth capital facility prevails. It also reports $100 million received in the first tranche.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Growth growth capital facility | $185M | 2026-09-29 | Hercules Capital | 6 outlets. #13 in Trending |
6 sources [ VERIFIED ] read against 4 of 6 sources Source 1 calls this a funding round and describes convertible preferred shares; the company release’s more specific description of a growth capital facility prevails. It also reports $100 million received in the first tranche. | ||||